PTPRZ1 regulates calmodulin phosphorylation and tumor progression in small-cell lung carcinoma

BMC Cancer
Hideki MakinoshimaAtsushi Ochiai


Small-cell lung carcinoma (SCLC) is a neuroendocrine tumor subtype and comprises approximately 15% of lung cancers. Because SCLC is still a disease with a poor prognosis and limited treatment options, there is an urgent need to develop targeted molecular agents for this disease. We screened 20 cell lines from a variety of pathological phenotypes established from different organs by RT-PCR. Paraffin-embedded tissue from 252 primary tumors was examined for PTPRZ1 expression using immunohistochemistry. shRNA mediated PTPRZ1 down-regulation was used to study impact on tyrosine phosphorylation and in vivo tumor progression in SCLC cell lines. Here we show that PTPRZ1, a member of the protein tyrosine- phosphatase receptor (PTPR) family, is highly expressed in SCLC cell lines and specifically exists in human neuroendocrine tumor (NET) tissues. We also demonstrate that binding of the ligand of PTPRZ1, pleiotrophin (PTN), activates the PTN/PTPRZ1 signaling pathway to induce tyrosine phosphorylation of calmodulin (CaM) in SCLC cells, suggesting that PTPRZ1 is a regulator of tyrosine phosphorylation in SCLC cells. Furthermore, we found that PTPRZ1 actually has an important oncogenic role in tumor progression in the murine xenograft model...Continue Reading


Jul 20, 1999·European Journal of Biochemistry·C CortiE Carafoli
Aug 3, 2002·European Journal of Biochemistry·Gustavo Benaim, Antonio Villalobo
Oct 12, 2002·The Journal of Biological Chemistry·Christophe BlanchetotJeroen den Hertog
Oct 14, 2003·Oncogene·Sabine MüllerThorsten Melcher
Dec 25, 2003·Journal of Neuropathology and Experimental Neurology·Ulrike UlbrichtKatrin Lamszus
Mar 12, 2004·Cancer Letters·Kenji Kadomatsu, Takashi Muramatsu
May 25, 2004·Science·Zhenghe WangVictor E Velculescu
Apr 9, 2005·The Journal of Endocrinology·Andrew W Stoker
Nov 22, 2005·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Emma L Williams, Mustafa B A Djamgoz
Jun 24, 2006·Nature Reviews. Cancer·Dai FukumuraRakesh K Jain
Oct 24, 2006·Nature Reviews. Molecular Cell Biology·Nicholas K Tonks
Aug 21, 2008·The Journal of Biological Chemistry·Jeremy Pak Hong ChowMasaharu Noda
Jun 29, 2010·Cancer Treatment Reviews·Young Hak Kim, Michiaki Mishima
Jul 29, 2010·Pancreas·Matthew H KulkeNorth American Neuroendocrine Tumor Society (NANETS)
Oct 1, 2010·Archives of Gynecology and Obstetrics·Yaxi MaWeiguo Lu
Nov 5, 2010·Journal of Proteome Research·Hye-Cheol JeongKwang-Hoe Chung
Dec 24, 2010·Nature Reviews. Cancer·Sofi G JulienMichel L Tremblay
Jun 22, 2011·Nature Reviews. Clinical Oncology·William N William, Bonnie S Glisson


Dec 27, 2013·BMC Systems Biology·Meeta P PradhanMathew J Palakal
Nov 25, 2014·Molecular Carcinogenesis·Geetika SethiAndrew K Godwin
Nov 6, 2013·Biochimica Et Biophysica Acta·M W Berchtold, Antonio Villalobo
Oct 6, 2016·Biochimica Et Biophysica Acta·Evangelia PapadimitriouDimitris Beis
Feb 10, 2016·Scientific Reports·Akihiro FujikawaMasaharu Noda
Apr 12, 2019·Interdisciplinary Sciences, Computational Life Sciences·Anil Kumar TomarBishwajit Kundu
Apr 30, 2017·Journal of Alzheimer's Disease : JAD·Petra MajerovaAndrej Kovac
Apr 15, 2019·Journal of Molecular Neuroscience : MN·Harish JoshiChanabasayya Vastrad
Dec 24, 2018·The Biochemical Journal·Antonio Villalobo

Methods Mentioned

flow cytometry

Related Concepts

Related Feeds

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.